JNJ today
$280.41-$0.37 (-0.13%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourAscending Triangle
1 hourBullish
15 minBullish
5 minBullish
Daily trend turns down below $245.17
Key levels
Resistance$283.25
Support$275.23
Support$265.28
Latest news & SEC filings
ProductJ&J posts positive results from bipolar disorder trial
NewsJohnson & Johnson to present hematology portfolio data at ASH 2026
LegalPanel in California orders $34.21 million payout in talc-asbestos mesothelioma suit
ProductJohnson & Johnson reports positive Phase 3 results for CAPLYTA in bipolar mania
All JNJ news →About Johnson & Johnson
Johnson & Johnson is a healthcare holding company that runs two segments: Innovative Medicine and MedTech. The Innovative Medicine segment develops prescription drugs in areas such as cancer, immune disorders, brain and mood conditions, pulmonary hypertension, infectious diseases, and heart and metabolic conditions, reaching customers through wholesale and retail channels, medical facilities, and clinicians. The MedTech segment makes devices for heart care, bone and joint repair, surgical procedures, and eye care, including electrophysiology tools, joint implants, surgical instruments, contact lenses, and lens implants for cataract surgery, sold through distributors, medical centers, and stores. The company operates around the world.
Based on the company's 10-K filed Feb 11, 2026.
NYSE · Healthcare
JOHNSON & JOHNSON (JNJ)
What Is the Price Target for JNJ?
SEPT Low Target
$250.00
SEPT Mid Target
$287.00
SEPT High Target
$320.00
Analyst Consensus
$287.00
Is JNJ a Buy or Sell Right Now?
Thesis
- •Revenue growing 6.0% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for JNJ.
Start Free Trial →Is JNJ Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$327.01
57
Moat Score
NARROW
5/9
Piotroski Score
5.0
Altman Z-Score
What Is Smart Money Doing with JNJ?
Insider Signal
SELLING
0 buys / 9 sells (90d)
Congress Signal
BUYING
7 buys / 13 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Broadhurst Vanessa | officer | Buy | 11,129 | $1.4M | Jul 20, 2026 |
| Broadhurst Vanessa | officer | Buy | 11,925 | $1.6M | Jul 20, 2026 |
| Broadhurst Vanessa | officer | Sale | 23,054 | $5.8M | Jul 20, 2026 |
| Wengel Kathryn E | officer | Buy | 10,000 | $1.2M | Jun 11, 2026 |
| Wengel Kathryn E | officer | Sale | 10,000 | $2.4M | Jun 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →JNJ Growth Story
Revenue YoY
6.0%
3yr Revenue CAGR
5.6%
EPS Growth YoY
90.5%
FCF Growth YoY
-0.7%
Revenue Trend
STABLE
Dark Pool Trades for JNJ
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for JNJ, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 09:33:19 | $281.67 | 4,208 | $$1.2M | SELL |
| 23:57:47 | $280.41 | 1,833 | $$514K | SELL |
| 22:25:08 | $280.41 | 44,043 | $$12.4M | SELL |
| 21:28:25 | $280.41 | 37,584 | $$10.5M | SELL |
| 21:21:59 | $280.41 | 2,165 | $$607K | SELL |
5 dark pool trades shown · $$25.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for JNJ
PREVIEWSEPT Investing provides real-time options flow tracking for JNJ, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $292.5 | Nov 13 | 2 | $$6 | 1 | SWEEP |
| CALL | $292.5 | Nov 13 | 2 | $$6 | 1 | SWEEP |
| CALL | $292.5 | Nov 13 | 2 | $$12 | 2 | SWEEP |
| CALL | $292.5 | Nov 13 | 2 | $$18 | 3 | SWEEP |
| CALL | $292.5 | Nov 13 | 2 | $$6 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for JOHNSON & JOHNSON (JNJ) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →JNJ — frequently asked questions
What is JNJ stock price today?
JOHNSON & JOHNSON (JNJ) is at $280.41, down 0.13% (-$0.37) at the Nov 11, 2026 close.
Why is JNJ stock moving today?
Latest JNJ news — Nov 11, 2026: J&J posts positive results from bipolar disorder trial · Nov 11, 2026: Johnson & Johnson to present hematology portfolio data at ASH 2026
What is the JNJ price target?
The average analyst price target for JNJ is $287.00, ranging from $250 to $320, based on 15 analysts. Latest: Wells Fargo maintains on Oct 16, 2026.
What do analysts rate JNJ?
Analyst ratings for JNJ: 1 Buy, 28 Hold, 1 Sell — consensus Hold.
Did JNJ beat earnings?
JNJ last reported on Oct 13, 2026: EPS $2.59 vs $2.52 expected — a beat of 2.8%.
What is JNJ's P/E ratio?
JNJ trades at a P/E of 40.5 vs a Healthcare average of 17.7.
Does JNJ pay a dividend?
Yes. JNJ's dividend yield is 2.46%.
What are JNJ support and resistance levels?
Support: $275.23, $265.28, $255.25. Resistance: $283.25.
What are insiders doing with JNJ?
Insider activity: SELLING, 0 buys and 9 sells in the last 90 days.
What is the latest news on JNJ?
Nov 11, 2026: J&J posts positive results from bipolar disorder trial · Nov 11, 2026: Johnson & Johnson to present hematology portfolio data at ASH 2026 · Nov 10, 2026: Panel in California orders $34.21 million payout in talc-asbestos mesothelioma suit